COMPOSITION PHARMACEUTIQUE COMPRENANT UN AGENT INHIBITEUR DE L'ENZYME HMG-COA REDUCTASE ET UN AGENT INHIBITEUR DE L'ENZYME LIPASE GATROINTESTINAL

• 收藏
• 分享

专利权人:

PPTM INTERNATIONAL S.À R.L.

发明人:

申请号：

EP08778967.3

公开号：

EP2179732B1

申请日:

2008.06.16

申请国别(地区):

EP

年份:

2014

代理人:

摘要：

The present invention refers to a pharmaceutical composition comprising a synergic combination of an enzyme HMG-CoA reductase inhibiting agent, such as active principle atorvastatin and a gastrointestinal lipase enzyme inhibiting agent, such as active principle orlistat, which are formulated in a single dosage unit to be administered orally, for treatment and control of diseases such as dyslipidemias (hypercholesterolemia and hypertriglyceridemia) and other related conditions.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/